Product information
From Health Canada
Current status:
Approved
Current status date:
2023-04-18
Product name:
FINLIUS I.V.
Description:
SINGLE-USE VIAL
DIN:
02537311 Electronic product monograph is not available
Company:
JANSSEN INC
19 Green Belt Drive
Toronto
Ontario
Canada
M3C 1L9
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription , Schedule D
American Hospital Formulary Service (AHFS): See footnote 3
92:20.00 , 84:92.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
L04AC05 USTEKINUMAB
Active ingredient group (AIG) number:See footnote5
0152506002
Active ingredient(s) | Strength |
---|---|
USTEKINUMAB | 5 MG / ML |